KMT2C and breast cancer: These findings are independently corroborated from publicly available data from the cancerrxgene.org database 62, which show that cell lines from BC, NSCLC, HNSCC, and COAD with reduced expression of KMT2C are more sensitive to PARPi (Fig 8C).